HIV 101: Foundations of Management of People Who Are Newly Diagnosed With HIV

Assessment of Needs

A firm grasp of the basics of clinical care for patients with HIV is essential for practitioners in Ryan White HIV/AIDS-funded clinics and programs who are new to HIV care. In this webinar, experts in the field described the core principles of HIV management, including pathogenesis of HIV infection and mechanisms of action of antiretroviral drugs, as well as initiating antiretroviral therapy and primary care for people who are newly diagnosed with HIV. This webinar is also useful to experienced clinicians who seek a review of these core principles.

Learning Objectives

HIV 101: Fundamentals of HIV Pathogenesis, Antiretroviral Therapy, and Drug Resistance
Presenter: Michael S. Saag, MD
University of Alabama at Birmingham

Learning Objectives
On completion of this activity, learners will be able to:

• Describe the pathogenesis of HIV disease and the life cycle of HIV
• Describe how to use knowledge of the pathogenesis of HIV in clinical practice
• Describe the basic mechanisms of drug resistance

HIV 101: Primary Care for People Newly Diagnosed With HIV
Presenter: Carolyn Chu, MD, MSc
University of California San Francisco

Learning Objectives
On completion of this activity, learners will be able to:

• Conduct an initial assessment of a person newly diagnosed with HIV, including conducting a patient history, ordering appropriate tests, and devising a plan to ensure engagement in care
• Describe the timing of appropriate vaccinations for people newly diagnosed with HIV
• Describe how to provide continuous monitoring for antiretroviral therapy success and for the emergence of comorbid conditions, including cardiovascular disease, renal disease, frailty, and other clinical presentations

HIV 101: Initiation of Antiretroviral Therapy
Presenter: Roy M. Gulick, MD, MPH
Weill Cornell Medicine
New York, NY

Learning Objectives
On completion of this activity, learners will be able to:

• Initiate an appropriate antiretroviral therapy (ART) regimen in a person newly diagnosed with HIV according to their clinical presentation and preference
• Describe the concept of drug resistance testing and its role in maintaining appropriate ART regimens
• Describe appropriate ART regimens for special populations

Registration

Who Should Attend

This program is designed for clinical decision-makers in Ryan White HIV/AIDS Program (RWHAP)-funded clinics and programs who are new to HIV care and those practitioners who are interested in a review. It is also relevant for registered nurses, pharmacists, and other health care professionals.

Individual registration is required in order to receive CME credit or a certificate of participation.

Registration closes on Thursday, September 25, 12:30 PM (PT).

For more information or questions, please contact the registration department at registration@iasusa.org or 415-544-9400.

Conflicts of Interest

In the interest of maintaining the independence of its continuing medical education (CME) activities, the International Antiviral Society–USA (IAS–USA) requires all persons with control of educational content (eg, faculty, Scientific Leadership Board, Governance Board, and program planner) to disclose any financial relationships with ineligible companies (previously defined as “commercial interests”) that they have had within the past 24 months. Any real or apparent conflicts of interest of those parties are resolved and mitigated prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in IAS–USA CME activities.

The Accreditation Council for Continuing Medical Education (ACCME) defines ineligible companies as “those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.”

IAS–USA will identify and resolve ahead of time any possible conflicts of interest that may influence CME activities with regard to exposition or conclusion. Information about financial relationships with ineligible companies for the presenter and planners/reviewers is below and in the slides prior to the presentation of educational content.

COW Board

The financial relationships of the COW Board can be found here: https://www.iasusa.org/activities/cases-on-the-web/about-cows/cow-webinars-editorial-board/